AssayIndex
JEEP cross-section

JEEP by compound

JEEP records split by compound, with the index-wide comparison for the same compound beside each one. 28 compounds, 283 records. Cells below n=3 print their raw values instead of a median.

28 compounds283 records
CompoundClassReportsJEEP median %Index median %Δ (pp)SpecPass %
BPC-157Tissue-repair4399.4199.15+0.2698.0100
SemaglutideIncretin3999.1398.87+0.2697.0100
TirzepatideIncretin2999.1798.44+0.7397.0100
TB-500Tissue-repair2699.7299.47+0.2598.5100
MK-677 (Ibutamoren mesylate)Non-peptide1399.6099.37+0.2398.5100
CJC-1295 with DACGrowth-hormone1299.2198.79+0.4297.5100
N-Acetyl Semax AmideNeuroactive1299.9399.26+0.6798.5100
LiraglutideIncretin1299.4899.02+0.4697.5100
SS-31 (Elamipretide)Metabolic1199.3999.42-0.0398.5100
PT-141 (Bremelanotide)Melanocortin-receptor1099.4499.31+0.1398.5100
RetatrutideIncretin998.0098.41-0.4196.5100
LeuprolideHypothalamic999.0699.01+0.0598.589
ARA-290Tissue-repair899.0299.45-0.4498.0100
MOTS-cMetabolic899.6799.18+0.4998.0100
Melanotan IIMelanocortin-receptor5 n=599.5799.24+0.3398.5100
L-Glutathione (reduced)Short5 n=599.0899.00+0.0898.5100
SemaxNeuroactive5 n=599.0999.17-0.0898.5100
GHRP-2Growth-hormone5 n=599.4199.22+0.1999.080
GHRP-6Growth-hormone5 n=599.5799.65-0.0899.0100
IGF-1 DES (1-3)Growth-hormone3 n=399.7598.53+1.2295.0100
HexarelinGrowth-hormone2 n=2n<398.7299.0100
CagrilintideIncretin2 n=2n<398.5996.5100
IGF-1 LR3Growth-hormone2 n=2n<397.7595.0100
5-Amino-1MQNon-peptide2 n=2n<399.2498.0100
EpitalonShort2 n=2n<398.6399.0100
KPVTissue-repair2 n=2n<399.2199.0100
ThymulinTissue-repair1 n=1n<399.0698.0100
PinealonShort1 n=1n<399.2499.0100
97.297.798.298.799.299.6100.1BPC-157BPC-157: Q1 99.07, median 99.41, Q3 99.80, n=43n=43SemaglutideSemaglutide: Q1 98.87, median 99.13, Q3 99.56, n=39n=39TirzepatideTirzepatide: Q1 98.82, median 99.17, Q3 99.48, n=29n=29TB-500TB-500: Q1 99.52, median 99.72, Q3 99.93, n=26outlier 98.85outlier 98.86n=26MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 99.38, median 99.60, Q3 99.91, n=13n=13CJC-1295 with DACCJC-1295 with DAC: Q1 98.93, median 99.21, Q3 99.58, n=12n=12N-Acetyl Semax AmideN-Acetyl Semax Amide: Q1 99.86, median 99.93, Q3 99.93, n=12outlier 99.66n=12LiraglutideLiraglutide: Q1 99.24, median 99.48, Q3 99.66, n=12n=12SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 99.04, median 99.39, Q3 99.63, n=11n=11PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.22, median 99.44, Q3 99.72, n=10n=10RetatrutideRetatrutide: Q1 97.97, median 98.00, Q3 98.64, n=9n=9LeuprolideLeuprolide: Q1 98.89, median 99.06, Q3 99.85, n=9n=9ARA-290ARA-290: Q1 98.79, median 99.02, Q3 99.12, n=8outlier 99.63n=8MOTS-cMOTS-c: Q1 99.34, median 99.67, Q3 99.76, n=8outlier 98.58n=8 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.